A CRITICAL REVIEW ON COLON TARGETED DRUG DELIVERY SYSTEMS FOR MANAGEMENT OF INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Jaiswal, Meenakshi [1 ]
Lanjhiyana, S. K. [1 ]
机构
[1] Guru Ghasidas Vishwavidyalaya, SLT Inst Pharmaceut Sci, Dept Pharmaceut, Bilaspur 495009, Chhattisgarh, India
关键词
Colon-specific drug delivery; Colonic disease; Inflammatory disease; Gastrointestinal tract; Evaluation of drugs targeting colon; THERAPY; CANCER;
D O I
10.13040/IJPSR.0975-8232.10(3).985-92
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inflammatory bowel disease (IBD) refers to the inflammation of the colon and small intestine of the body, in which Crohn's disease and ulcerative colitis are the principal types of IBD. This article covers most of the information related to a drug delivery system for treatment regarding intestinal diseases more emphasized to inflammatory bowel diseases. Currently, using delivery systems for targeting drugs to colon are osmotic drug delivery system, chronotropic system, pulsinicap system, multiparticulate system, port system, COLAL-Pred system, gas empowered drug delivery system have included in this article. An approach for targeting drugs to the colon is a probiotic approach has also included in this article. These delivery systems are being used to improve the bioavailability of the poorly absorbed drug. The purpose of this review article is to study about techniques employed in colon targeting for the prevention and treatment of IBD.
引用
收藏
页码:985 / 992
页数:8
相关论文
共 50 条
  • [41] Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment
    Gao, Jian
    Li, Jiannan
    Luo, Zengyou
    Wang, Hongyong
    Ma, Zhiming
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2921 - 2949
  • [43] TARGETED COLON DELIVERY OF NIPEP-IM-0127 PEPTIDE FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
    Kim, Deogil
    Lee, Dong Woo
    Jo, Beom Soo
    Park, Yoon Shin
    Lee, Jue Yeon
    Park, Yoon Jeong
    Chung, Chong Pyung
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S35 - S35
  • [44] TARGETED COLON DELIVERY OF NIPEP-IM-0127 PEPTIDE FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
    Kim, Deogil
    Lee, Dong Woo
    Jo, Beom Soo
    Park, Yoon Shin
    Lee, Jue Yeon
    Park, Yoon Jeong
    Chung, Chong Pyung
    GASTROENTEROLOGY, 2020, 158 (03) : S56 - S56
  • [45] Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems
    Di Rienzo, Annalisa
    Marinelli, Lisa
    Dimmito, Marilisa Pia
    Toto, Eleonora Chiara
    Di Stefano, Antonio
    Cacciatore, Ivana
    PHARMACEUTICS, 2024, 16 (09)
  • [46] Drug delivery strategies in the therapy of inflammatory bowel disease
    Lautenschlaeger, Christian
    Schmidt, Carsten
    Fischer, Dagmar
    Stallmach, Andreas
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 71 : 58 - 76
  • [47] Probiotics in inflammatory bowel disease: a critical review
    Tamboli, CP
    Caucheteux, C
    Cortot, A
    Colombel, JF
    Desreumaux, P
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (05) : 805 - 820
  • [48] Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
    Li, De-feng
    Yang, Mei-feng
    Xu, Hao-ming
    Zhu, Min-zheng
    Zhang, Yuan
    Tian, Cheng-mei
    Nie, Yu-qiang
    Wang, Jian-yao
    Liang, Yu-jie
    Yao, Jun
    Wang, Li-sheng
    JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (31) : 5853 - 5872
  • [49] Review: Colon Capsule Endoscopy in Inflammatory Bowel Disease
    Halder, Writaja
    Laskaratos, Faidon-Marios
    El-Mileik, Hanan
    Coda, Sergio
    Fox, Stevan
    Banerjee, Saswata
    Epstein, Owen
    DIAGNOSTICS, 2022, 12 (01)
  • [50] Implants as Targeted Drug Delivery Systems (Review)
    E. O. Bakhrushina
    N. B. Demina
    Pharmaceutical Chemistry Journal, 2022, 56 : 396 - 402